 | Arvinas, Inc. | |||
| NMS : ARVN || Location: United States | ||||
$31.6-0.94 (-2.89%) |
0.62 M | 30.91 - 32.13 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 8.942 M |
| March 28, 2024 | 8.600 M |
| March 15, 2024 | 7.925 M |
| Feb. 29, 2024 | 8.355 M |
| Feb. 15, 2024 | 7.769 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -1.29 | -2.53 | -95.64% |
| 09/30/2023 | -1.61 | -1.18 | 26.59% |
| 06/30/2023 | -1.68 | -1.25 | 25.67% |
| 03/31/2023 | -1.54 | -1.54 | -0.08% |
| 12/31/2022 | -1.18 | -1.56 | -31.81% |
ARVN Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 68.308M | Shares Float | 52.430M |
| Short Float | 8.942M | Market Cap | 2222.74M |
| Institution ownership | 96.95% | Insider ownership | 2.552% |
| Earnings Date | 04/30/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -6.62 | Forward EPS | -5.62 |